TANYA POWERS: Open Payments
NPI 1760105589 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 21 payments from 8 companies in 2025. Trend: 2023 $228 · 2024 $225 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $155 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| ABIOMED | 1 | $41 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Abbott Laboratories | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 2 | $14 |
Products named: Ozempic, REXULTI, GEMTESA, XIFAXAN, Wegovy, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, VOQUEZNA.
Industry payments across WV — which companies pay providers there.
